Global Sleep Gummies Market to Flourish at a CAGR of Around 6.38% During 2026-32

The global sleep gummies market was valued at USD 1.2 billion in 2025 and is projected to reach USD 1.8 billion in 2026 and USD 3.0 billion by 2032, registering a CAGR of 6.38% during 2026–32. The market is witnessing steady expansion driven by rising sleep disorders, stress-driven lifestyles, irregular routines, and increasing screen exposure, alongside growing preference for preventive wellness and functional nutraceutical solutions.

Furthermore, rising sleep health concerns are strongly supported by public health data, with the U.S. CDC reporting 30.5% of adults sleeping less than seven hours per night, while the NIH estimates 50–70 million individuals suffer from sleep or wakefulness disorders. Consequently, consumers are increasingly shifting toward non-prescription sleep gummies as safer, convenient alternatives, supported by expanding sleep health awareness programs and behavioral research initiatives.

Additionally, the market is undergoing a notable shift toward clean-label and plant-based formulations, driven by growing demand for transparent, natural, and vegan-friendly wellness products. In 2024, Sirio Pharma introduced melatonin-free sleep gummy concepts featuring ingredients such as L-theanine, chamomile, and valerian root, while Charlotte’s Web launched its CBN-based plant-derived sleep gummies, reflecting strong innovation in botanical sleep support solutions globally.

Moreover, melatonin remains the dominant ingredient segment, accounting for nearly 50% share due to its strong association with circadian rhythm regulation and sleep onset support. Additionally, the sleep initiation function holds around 37% share in 2026, driven by increasing difficulty in falling asleep caused by stress, screen exposure, and irregular schedules, supported by innovation in fast-acting and combination formulations across markets.

Furthermore, North America dominates the global landscape with approximately 43% share, supported by high consumer awareness, strong nutraceutical adoption, and widespread retail penetration through pharmacies and supermarket chains, during the forecast period, further states the research report, “Global Sleep Gummies Market Analysis, 2026.”

Global Sleep Gummies Market Highlights

The Global Sleep Gummies Market was valued at USD 1.2 billion in 2025 and is projected to rise from USD 1.8 billion in 2026 to USD 3.0 billion by 2032’
The industry is projected to registering a CAGR of 6.38% during 2026–32, supported by rising sleep disorder prevalence, increasing stress-related lifestyle disruptions, and growing adoption of non-prescription nutraceutical sleep-support solutions.
By ingredient type, melatonin holds a dominant share of nearly 50% in the Global Sleep Gummies Market, driven by its strong association with circadian rhythm regulation, sleep onset support, and widespread acceptance as a first-line non-prescription sleep aid, particularly in North America.
In terms of function, the sleep initiation segment accounts for approximately 37% share in 2026, supported by rising difficulty in falling asleep due to stress, irregular routines, and increased screen exposure, along with growing adoption of fast-acting, combination nutraceutical formulations.
The market remains moderately fragmented, with key players such as including Church & Dwight Inc. (Olly), Nature’s Bounty, Natrol, Nature Made (Pharmavite), and CVS Health collectively accounting for nearly 43% share, reflecting strong dominance of established nutraceutical companies supported by continuous product innovation in clean-label, plant-based, and blended sleep-support formulations.

Global Sleep Gummies Market Segmentation

By Ingredient Type
- Melatonin
- L-Theanine
- Magnesium
- Valerian Root
- CBD/CBN
By Product Form
- Regular sleep gummies
- Sugar-free variants
- Vegan / plant-based formulations
- Organic / clean-label products
- Functional blends
By Function
- Sleep initiation
- Sleep maintenance
- Stress & relaxation support
- Sleep cycle regulation
- Recovery & restorative sleep enhancement
By Distributional Channel
- Retail Pharmacies
- Online Platforms
- Supermarkets/Hypermarkets
- Direct-to-consumer
By Region
- North America
- South America
- Europe
- Middle East and Africa
- Asia Pacific